UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, ~~DC 20549~~ DC20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March ~~November 3~~16, ~~2005~~2007

Karver International, Inc.

(Exact name of Registrant as specified in its charter)

New York		333-46828		13-3526402
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(I.R.S. Employer Identification No.)

825 Third Avenue, 40th Floor, New York, New York		10022
601 Brickell Key Drive, Suite 901, Miami, Florida		33131
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (~~212~~305) ~~838 2585~~350-3996

~~Medeorex,~~Not ~~Inc.~~ Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material ~~Written communications~~ pursuant to Rule ~~425~~14a-12 under the ~~Securities~~Exchange Act (17 CFR ~~230~~ 240.~~425)~~14a-12

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5 8.~~03 Amendments to Articles of Incorporation~~01 Other ~~or Bylaws; Change in Fiscal Year~~ Events

~~Effective~~ ~~November~~The 3,Registrant’s ~~2005,~~agreement ~~the~~to ~~Registrant~~purchase ~~amended~~all ~~its~~of ~~Certificate~~the outstanding common stock of Gemoscan ~~Incorporation~~International, Inc., a Toronto-based company engaged in diagnosing toand ~~change~~providing ~~its~~solutions ~~name~~for ~~from~~the ~~“Medeorex,~~treatment ~~Inc.”~~of tofood ~~“Karver~~intolerances ~~International~~(“Gemoscan”), ~~Inc.” The~~has ~~amendment~~been ~~was~~terminated ~~approved~~ by the ~~Registrant’s~~parties. In ~~board~~connection ofwith ~~directors~~the ~~and~~termination, ~~its~~the ~~shareholders~~Registrant and Gemoscan executed a mutual general release.

Item 9.01 Financial Statements and Exhibits

Number Description of Document

3.1 Certificate of Amendment of the Certificate of Incorporation.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Medeorex, Inc. (Registrant)
	Karver International, Inc.
Date: November 9, 2005	By:	/s/ Dr. Jack Kachkar
March 22, 2007	By:	/s/ Dr. Jack Kachkar
		Dr. Jack Kachkar
		Chairman and President

Filing Compare · Karver International, Inc.